Latest News & Features
Generics
Following two-day oral proceedings at the Munich Board of Appeal of the European Patent Office, the court has upheld the validity of a Bayer Pharmaceuticals’ dosing patent for Xarelto. 4 November 2021
Medtech
The US Court of Appeals for the Federal Circuit has ruled that yet another CardioNet heart monitor patent is invalid for not citing an inventive concept under the Alice test. 2 November 2021
Americas
Medical device company Nevro has been hit with a $20m damages verdict after a US jury found that it had infringed two patents owned by Boston Scientific. 2 November 2021
Big Pharma
Mylan has failed to secure a stay in litigation centring on a melatonin-based insomnia patent at the English High Court. 2 November 2021
Big Pharma
UN-backed public health organisation The Medicine Patent Pool (MPP) has entered into a licence agreement with Merck Sharp & Dohme (MSD) and others to increase access to molnupiravir (MK-4482, EIDD-2801)—an investigational oral COVID-19 medicine—for low-and-middle-income countries (LMIC). 28 October 2021
Americas
Azurity Pharmaceuticals has sued Florida-based generic manufacturer CoreRx for infringing a pair of patents covering a hypertension drug for children. 28 October 2021
article
The US Patent Trial and Appeal Board (PTAB) has granted a review of a Novartis syringe patent following a challenge from biotech giant Regeneron. 28 October 2021
Medtech
Boston Scientific (BSC) and Nevro will testify before a Delaware Federal Court today following pleas from Nevro to delay the trial due to claims that BSC destroyed evidence related to a patent damages case. 26 October 2021
Americas
St Jude Medical will be able to claw back some of the attorney fees and expenses it incurred defending a suit filed by Niazi Licensing Corporation in a dispute over a patent covering a heart catheter. 26 October 2021
Americas
Bausch & Lomb has accused a Nashville-based ophthalmic company of infringing two patents covering its eye-brightening drops, Lumify. 26 October 2021